BIIB
Price:
$200.81
Market Cap:
$29.25B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1991-09-17
Stock Exchange
NASDAQ
Ticker
BIIB
According to Biogen Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.29. This represents a change of 13.44% compared to the average of 2.02 of the last 4 quarters.
The mean historical Current Ratio of Biogen Inc. over the last ten years is 2.24. The current 2.29 Current Ratio has changed 10.13% with respect to the historical average. Over the past ten years (40 quarters), BIIB's Current Ratio was at its highest in in the September 2015 quarter at 3.52. The Current Ratio was at its lowest in in the September 2023 quarter at 1.68.
Average
2.24
Median
2.21
Minimum
1.72
Maximum
2.99
Discovering the peaks and valleys of Biogen Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.67%
Maximum Annual Current Ratio = 2.99
Minimum Annual Increase = -33.24%
Minimum Annual Current Ratio = 1.72
Year | Current Ratio | Change |
---|---|---|
2023 | 2.00 | -33.24% |
2022 | 2.99 | 63.67% |
2021 | 1.83 | -0.68% |
2020 | 1.84 | 6.79% |
2019 | 1.72 | -25.68% |
2018 | 2.32 | -0.80% |
2017 | 2.34 | -10.67% |
2016 | 2.62 | 0.67% |
2015 | 2.60 | 23.48% |
2014 | 2.11 | 16.21% |
The current Current Ratio of Biogen Inc. (BIIB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.27
5-year avg
2.08
10-year avg
2.24
Biogen Inc.’s Current Ratio is greater than Bristol-Myers Squibb Company (1.16), greater than AbbVie Inc. (0.81), greater than Merck & Co., Inc. (1.47), greater than Gilead Sciences, Inc. (1.14), greater than Johnson & Johnson (1.07), greater than Amgen Inc. (1.26), greater than Pfizer Inc. (0.86), greater than Sanofi (1.00), greater than Novartis AG (0.93), greater than GSK plc (0.82),
Company | Current Ratio | Market cap |
---|---|---|
1.16 | $98.73B | |
0.81 | $341.61B | |
1.47 | $298.70B | |
1.14 | $98.01B | |
1.07 | $395.70B | |
1.26 | $172.25B | |
0.86 | $161.84B | |
1.00 | $144.70B | |
0.93 | $228.22B | |
0.82 | $89.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Biogen Inc.'s Current Ratio?
How is the Current Ratio calculated for Biogen Inc. (BIIB)?
What is the highest Current Ratio for Biogen Inc. (BIIB)?
What is the 3-year average Current Ratio for Biogen Inc. (BIIB)?
What is the 5-year average Current Ratio for Biogen Inc. (BIIB)?
How does the current Current Ratio for Biogen Inc. (BIIB) compare to its historical average?